AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16384587 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group 1) without training
Number of subjects: 30
Study 15176685 — intervention group
Group type: EXPERIMENTAL
Intervention: Clarithromycin 250 mg b.i.d. for 8 weeks (Arm A)
Number of subjects: 30
Study 15176685 — intervention group
Group type: EXPERIMENTAL
Intervention: Clarithromycin 250 mg t.i.d. (Arm B)
Number of subjects: 30
Study 15176685 — intervention group
Group type: COMPARATOR
Intervention: Placebo dextrose tablets (Arm C)
Number of subjects: 30
Study 11528262 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical betaxolol
Number of subjects: 22
Study 11528262 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical dorzolamide
Number of subjects: 22
Study 11528262 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical apraclonidine
Number of subjects: 22
Study 9437230 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1 (400 micrograms buccal tablet)
Number of subjects: 16
Study 9437230 — intervention group
Group type: COMPARATOR
Intervention: Fasting state
Number of subjects: 16
Study 8279693 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 micrograms.kg‐1 ondansetron
Number of subjects: 100
Study 8279693 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 micrograms.kg‐1 ondansetron
Number of subjects: 100
Study 8279693 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 100
Study 8279693 — intervention group
Group type: EXPERIMENTAL
Intervention: Lysin acetylsalicylate (LAS)
Number of subjects: 100
Study 3828171 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-loop computer system delivering sodium nitroprusside infusion
Number of subjects: 60
Study 3828171 — intervention group
Group type: COMPARATOR
Intervention: Manual control by nursing staff
Number of subjects: 60
Study 29871619 — intervention group
Group type: EXPERIMENTAL
Intervention: Savings-led economic empowerment through youth development accounts (YDA)
Number of subjects: 1260
Study 29871619 — intervention group
Group type: EXPERIMENTAL
Intervention: Savings-led economic empowerment through youth development accounts (YDA) + Multiple Family Groups (MFG)
Number of subjects: 1260
Study 29871619 — intervention group
Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 1260
Study 26682533 — intervention group
Group type: EXPERIMENTAL
Intervention: Coke Zero
Number of subjects: 209
Study 26682533 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 209
Study 26682533 — intervention group
Group type: EXPERIMENTAL
Intervention: Coke Zero and Water
Number of subjects: 209
Study 25342385 — intervention group
Group type: EXPERIMENTAL
Intervention: 99mTc-MIP-1404
Number of subjects: 12
Study 25342385 — intervention group
Group type: EXPERIMENTAL
Intervention: 99mTc-MIP-1405
Number of subjects: 12
Study 25342385 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care bone scanning
Number of subjects: 12
Study 23137508 — intervention group
Group type: COMPARATOR
Intervention: HFpEF (n = 81)
Number of subjects: 300
Study 23137508 — intervention group
Group type: COMPARATOR
Intervention: HFpEF (n = 50)
Number of subjects: 300
Study 19763665 — intervention group
Group type: EXPERIMENTAL
Intervention: Early onset schizophrenia (EOS) patients
Number of subjects: 10
Study 19763665 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 10
Study 19763665 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with other non-affective psychoses
Number of subjects: 10
Study 18600411 — intervention group
Group type: EXPERIMENTAL
Intervention: (99m)Tc-DTPA aerosol scintigraphy
Number of subjects: 21
Study 18600411 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 21
Study 16084925 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitated programme supported by a trained external facilitator
Number of subjects: 22
Study 12593178 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient education programs for asthma; details on dosage and duration not specified.
Number of subjects: 0
Study 12593178 — intervention group
Group type: EXPERIMENTAL
Intervention: Education programs in COPD including self-management; details on dosage and duration not specified.
Number of subjects: 0
Study 12593178 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost effectiveness of education programs for asthmatics; details on dosage and duration not specified.
Number of subjects: 0
Study 10636350 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g of cefotaxime sodium diluted in 100 mL of isotonic sodium chloride solution (Group A)
Number of subjects: 84
Study 10636350 — intervention group
Group type: COMPARATOR
Intervention: 10 mL of isotonic sodium chloride solution in 100 mL of saline (Group B)
Number of subjects: 84
Study 10636350 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 84
Study 9190979 — intervention group
Group type: EXPERIMENTAL
Intervention: Retroperitoneal drainage (Group A, 68 patients)
Number of subjects: 137
Study 9190979 — intervention group
Group type: COMPARATOR
Intervention: No retroperitoneal drainage (Group B, 69 patients)
Number of subjects: 137
Study 1541883 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar diathermy
Number of subjects: 49
Study 1541883 — intervention group
Group type: COMPARATOR
Intervention: Ligation
Number of subjects: 49
Study 4041323 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine solution 4 ml without glucose
Number of subjects: 20
Study 4041323 — intervention group
Group type: COMPARATOR
Intervention: 0.5% bupivacaine solution 4 ml with glucose
Number of subjects: 20
Study 29960633 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone treatment
Number of subjects: 470
Study 29960633 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 470
Study 27157678 — intervention group
Group type: EXPERIMENTAL
Intervention: toggle recoil spinal manipulation
Number of subjects: 51
Study 27157678 — intervention group
Group type: COMPARATOR
Intervention: sham procedure
Number of subjects: 51
Study 24935040 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramyocardial injection of mobilized BMSCs
Number of subjects: 58
Study 24935040 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary injection of mobilized BMSCs
Number of subjects: 58
Study 24935040 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous granulocyte colony-stimulating factor injections
Number of subjects: 58
Study 24935040 — intervention group
Group type: COMPARATOR
Intervention: Saline injections only
Number of subjects: 58
Study 22810376 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiological catheter insertion using fluoroscopic guidance under local anaesthesia
Number of subjects: 113
Study 22810376 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic catheter insertion under general anaesthesia
Number of subjects: 113
Study 22810376 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall catheter survival
Number of subjects: 113
Study 22810376 — intervention group
Group type: EXPERIMENTAL
Intervention: Subject survival
Number of subjects: 113
Study 22810376 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic group
Number of subjects: 113
Study 20400900 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous infusion of 250 mg aspirin
Number of subjects: 234
Study 17239638 — intervention group
Group type: EXPERIMENTAL
Intervention: Azelastine (4 mg twice daily)
Number of subjects: 17
Study 17239638 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast (10 mg once daily)
Number of subjects: 17
Study 17239638 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of azelastine and montelukast
Number of subjects: 17
Study 17239638 — intervention group
Group type: COMPARATOR
Intervention: Control (none)
Number of subjects: 17
Study 15925031 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (0.3 mg/day)
Number of subjects: 12
Study 15925031 — intervention group
Group type: COMPARATOR
Intervention: Active placebo
Number of subjects: 12
Study 15315030 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin 1000 mg once a week
Number of subjects: 13
Study 15315030 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 9861095 — intervention group
Group type: EXPERIMENTAL
Intervention: HD-PNI risk (n = 208, 18%)
Number of subjects: 1527
Study 8896852 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol patient-controlled sedation (PCS) (n = 28)
Number of subjects: 55
Study 8896852 — intervention group
Group type: COMPARATOR
Intervention: No intraoperative sedation (n = 27)
Number of subjects: 55
Study 30908497 — intervention group
Group type: EXPERIMENTAL
Intervention: Head cooling (temperature-controllable cooling sheet at 25C)
Number of subjects: 14
Study 30908497 — intervention group
Group type: COMPARATOR
Intervention: Control (temperature at 35C)
Number of subjects: 14
Study 29944712 — intervention group
Group type: EXPERIMENTAL
Intervention: SDM-Digital Intake (SDM-DI)
Number of subjects: 200
Study 29944712 — intervention group
Group type: COMPARATOR
Intervention: Intake As Usual (IAU)
Number of subjects: 200
Study 27583108 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral corticosteroids (Group A)
Number of subjects: 54
Study 27583108 — intervention group
Group type: COMPARATOR
Intervention: Pregabalin or gabapentin (Group B)
Number of subjects: 54
Study 25100135 — intervention group
Group type: EXPERIMENTAL
Intervention: Trabectedin (1.3 mg/m², 3 h, i.v.) with rifampin (600 mg/day, 6 days)
Number of subjects: 20
Study 25100135 — intervention group
Group type: EXPERIMENTAL
Intervention: Trabectedin (0.58 mg/m², 3 h, i.v.) with ketoconazole (200 mg, twice-daily, 15 doses)
Number of subjects: 20
Study 25100135 — intervention group
Group type: COMPARATOR
Intervention: Trabectedin monotherapy (1.3 mg/m², 3 h, i.v.)
Number of subjects: 20
Study 22545740 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist-supported bibliotherapy
Number of subjects: 55
Study 22545740 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual therapy
Number of subjects: 55
Study 22545740 — intervention group
Group type: COMPARATOR
Intervention: Wait-list
Number of subjects: 55
Study 18952538 — intervention group
Group type: EXPERIMENTAL
Intervention: OAT (omeprazole, amoxicillin, tinidazole)
Number of subjects: 250
Study 18952538 — intervention group
Group type: EXPERIMENTAL
Intervention: OAC (omeprazole, amoxicillin, clarithromycin)
Number of subjects: 250
Study 18952538 — intervention group
Group type: EXPERIMENTAL
Intervention: OCT (omeprazole, clarithromycin, tinidazole)
Number of subjects: 250
Study 17366797 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery (esophagectomy with resection of the lesion and 5 cm margin, surrounding lymph nodes > or = 5 mm)
Number of subjects: 269
Study 17366797 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy (LCAHFR with total dose of 68.4-71.0 Gy)
Number of subjects: 269
Study 14728211 — intervention group
Group type: EXPERIMENTAL
Intervention: Support Vector Machine (SVM) model
Number of subjects: 7457
Study 14728211 — intervention group
Group type: EXPERIMENTAL
Intervention: SVM model with relative sentence location feature
Number of subjects: 7457
Study 14728211 — intervention group
Group type: COMPARATOR
Intervention: Linear Classifier model
Number of subjects: 7457
Study 14728211 — intervention group
Group type: EXPERIMENTAL
Intervention: SVM model trained on structured abstracts
Number of subjects: 7457
Study 11064608 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine 20.0 mg in 2.0 ml
Number of subjects: 12
Study 11064608 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine 5 mg in 2.0 ml
Number of subjects: 12
Study 11064608 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline 2.0 ml
Number of subjects: 12
Study 8984600 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylometazoline combined with S-carboxymethylcysteine
Number of subjects: 60
Study 8984600 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylephrine combined with dimethindene maleate
Number of subjects: 60
Study 8984600 — intervention group
Group type: COMPARATOR
Intervention: Benzydamine
Number of subjects: 60
Study 8984600 — intervention group
Group type: COMPARATOR
Intervention: NaCl (placebo)
Number of subjects: 60
Study 8984600 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzydamine or phenylephrine combined with dimethindene maleate
Number of subjects: 60
Study 1422657 — intervention group
Group type: EXPERIMENTAL
Intervention: Computed radiography using a 2K x 2K, 12‐bit storage phosphor plate system
Number of subjects: 50
Study 1422657 — intervention group
Group type: EXPERIMENTAL
Intervention: Edge-enhanced computed images
Number of subjects: 50
Study 1422657 — intervention group
Group type: COMPARATOR
Intervention: Conventional radiography
Number of subjects: 50
Study 3891227 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced visit adherence methods (appointment reminders, assistance with transportation, minimal waiting times, newsletters, continuity of care, involvement of family members, close contact with private physicians)
Number of subjects: 3837
Study 3891227 — intervention group
Group type: EXPERIMENTAL
Intervention: Visit adherence in BHAT
Number of subjects: 3837
Study 31977667 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 1300
Study 31977667 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine hydrochloride extended release
Number of subjects: 1300
Study 31977667 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose estradiol
Number of subjects: 1300
Study 31977667 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1300
Study 31977667 — intervention group
Group type: COMPARATOR
Intervention: Yoga
Number of subjects: 1300
Study 31977667 — intervention group
Group type: COMPARATOR
Intervention: Exercise
Number of subjects: 1300
Study 31977667 — intervention group
Group type: COMPARATOR
Intervention: Omega-3 supplementation
Number of subjects: 1300
Study 31977667 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy for insomnia
Number of subjects: 1300
Study 31977667 — intervention group
Group type: COMPARATOR
Intervention: Vaginal estradiol tablet
Number of subjects: 1300
Study 31977667 — intervention group
Group type: COMPARATOR
Intervention: Vaginal moisturizer
Number of subjects: 1300
Study 29873422 — intervention group
Group type: EXPERIMENTAL
Intervention: Model-based RSA in total wrist arthroplasties
Number of subjects: 40
Study 29873422 — intervention group
Group type: COMPARATOR
Intervention: Model-based RSA with less than four bone markers
Number of subjects: 40
Study 26784123 — intervention group
Group type: EXPERIMENTAL
Intervention: Reminder letter sent a few days before the breast screening appointment
Number of subjects: 22828
Study 26784123 — intervention group
Group type: COMPARATOR
Intervention: No reminder letter (control)
Number of subjects: 22828
Study 24812072 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat meal (500, 1000, and 1500 kcal, 60.5% energy from fat)
Number of subjects: 37
Study 24812072 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat meal (1500 kcal)
Number of subjects: 37
Study 24812072 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat meal (1000 kcal to 1500 kcal)
Number of subjects: 37
Study 22147061 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk information
Number of subjects: 286
Study 22147061 — intervention group
Group type: COMPARATOR
Intervention: Low-risk information
Number of subjects: 286
Study 20200432 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant micronutrient combination (800 mg dl‐alpha‐tocopherol acetate, 24 mg beta‐carotene, 1.0 g vitamin C, 200 microg l‐selenomethionine, 7.2 mg riboflavin, 80 mg niacin, 60 mg zinc, 5 mg manganese) given daily over 4 months
Number of subjects: 47
Study 20200432 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant micronutrient combination
Number of subjects: 47
Study 19088765 — intervention group
Group type: EXPERIMENTAL
Intervention: +CHO
Number of subjects: 9
Study 19088765 — intervention group
Group type: EXPERIMENTAL
Intervention: +CAF/-CHO
Number of subjects: 9
Study 19088765 — intervention group
Group type: EXPERIMENTAL
Intervention: -CAF/+CHO
Number of subjects: 9
Study 19088765 — intervention group
Group type: EXPERIMENTAL
Intervention: +CAF/+CHO
Number of subjects: 9
Study 19088765 — intervention group
Group type: COMPARATOR
Intervention: -CAF/-CHO
Number of subjects: 9
Study 15899687 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion SR
Number of subjects: 687
Study 15899687 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 687
Study 12780345 — intervention group
Group type: EXPERIMENTAL
Intervention: MUFA-enriched diet
Number of subjects: 31
Study 12780345 — intervention group
Group type: COMPARATOR
Intervention: HCLF diet
Number of subjects: 31
Study 10499750 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine (500 microg) + mepivacaine (500 mg)
Number of subjects: 34
Study 10499750 — intervention group
Group type: COMPARATOR
Intervention: Mepivacaine (500 mg) + saline (0.9%, 1 mL)
Number of subjects: 34
Study 8890061 — intervention group
Group type: EXPERIMENTAL
Intervention: Type 1 test food (20 kg)
Number of subjects: 13
Study 8890061 — intervention group
Group type: EXPERIMENTAL
Intervention: Type 2 test food (40 kg)
Number of subjects: 13
Study 8890061 — intervention group
Group type: EXPERIMENTAL
Intervention: Type 3 test food (1.0 kg)
Number of subjects: 13
Study 8890061 — intervention group
Group type: EXPERIMENTAL
Intervention: Type 4 test food (0.5 kg)
Number of subjects: 13
Study 8890061 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing order of test foods
Number of subjects: 13
Study 1800923 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy for Retinopathy of Prematurity (ROP)
Number of subjects: 4099
Study 6407402 — intervention group
Group type: EXPERIMENTAL
Intervention: Benoxaprofen 600 mg orally daily for 8 weeks
Number of subjects: 40
Study 6407402 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 6407402 — intervention group
Group type: EXPERIMENTAL
Intervention: Benoxaprofen
Number of subjects: 40
Study 29921786 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise at 70% V˙O2Peak (HIGH)
Number of subjects: 12
Study 29921786 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise at 40% V˙O2Peak (LOW)
Number of subjects: 12
Study 29921786 — intervention group
Group type: COMPARATOR
Intervention: Rest (CONTROL)
Number of subjects: 12
Study 27639738 — intervention group
Group type: EXPERIMENTAL
Intervention: PCI using XIENCE cobalt‐chromium everolimus‐eluting stents (CoCr‐EES)
Number of subjects: 1900
Study 27639738 — intervention group
Group type: COMPARATOR
Intervention: CABG (Coronary Artery Bypass Graft)
Number of subjects: 1900
Study 24920891 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled fluticasone propionate (FP; 500 μg twice daily for 6 months)
Number of subjects: 34
Study 24920891 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 22773616 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling sessions
Number of subjects: 65
Study 22773616 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention components
Number of subjects: 65
Study 22773616 — intervention group
Group type: EXPERIMENTAL
Intervention: PST components
Number of subjects: 65
Study 22773616 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence to study objectives
Number of subjects: 65
Study 22773616 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence to PST theory
Number of subjects: 65
Study 22773616 — intervention group
Group type: EXPERIMENTAL
Intervention: Counselor competence
Number of subjects: 65
Study 22773616 — intervention group
Group type: EXPERIMENTAL
Intervention: Counselor performance
Number of subjects: 65
Study 20962624 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose intravenous immunoglobulin (HD-IVIG)
Number of subjects: 646
Study 20962624 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose intravenous immunoglobulin (low-IVIG)
Number of subjects: 646
Study 18287826 — intervention group
Group type: EXPERIMENTAL
Intervention: True acupuncture
Number of subjects: 123
Study 18287826 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 123
Study 15723889 — intervention group
Group type: EXPERIMENTAL
Intervention: Social support interventions
Number of subjects: 12
Study 15643747 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive program
Number of subjects: 186
Study 15643747 — intervention group
Group type: EXPERIMENTAL
Intervention: Less comprehensive program
Number of subjects: 186
Study 15643747 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 186
Study 15643747 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 186
Study 15643747 — intervention group
Group type: EXPERIMENTAL
Intervention: Females
Number of subjects: 186
Study 15643747 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge and reported behavior correlation
Number of subjects: 186
Study 11114219 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg/d OXC
Number of subjects: 694
Study 11114219 — intervention group
Group type: EXPERIMENTAL
Intervention: 1200 mg/d OXC
Number of subjects: 694
Study 11114219 — intervention group
Group type: EXPERIMENTAL
Intervention: 2400 mg/d OXC
Number of subjects: 694
Study 11114219 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 694
Study 8788262 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary fish oil (FO) supplementation (5 food bars daily for 6 weeks)
Number of subjects: 19
Study 8788262 — intervention group
Group type: COMPARATOR
Intervention: Safflower oil (SO) (control group)
Number of subjects: 19
Study 1638170 — intervention group
Group type: EXPERIMENTAL
Intervention: brofaromine (150 mg daily)
Number of subjects: 30
Study 1638170 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 30
Study 6465821 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous indomethacin (50 mg)
Number of subjects: 60
Study 6465821 — intervention group
Group type: COMPARATOR
Intervention: Intravenous metamizole (2.5 g)
Number of subjects: 60
Study 29868796 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid injection (methylprednisolone)
Number of subjects: 30
Study 29868796 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozone (O2‐O3) injection
Number of subjects: 30
Study 29401242 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive contact with one older adult
Number of subjects: 302
Study 29401242 — intervention group
Group type: EXPERIMENTAL
Intervention: Increase in IOS
Number of subjects: 302
Study 29401242 — intervention group
Group type: EXPERIMENTAL
Intervention: Decrease in incompetence stereotypes
Number of subjects: 302